Robert Myles Elfont
Keine laufenden Positionen mehr
Karriereverlauf von Robert Myles Elfont
Ehemalige bekannte Positionen von Robert Myles Elfont
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2014 | - |
Ausbildung von Robert Myles Elfont
| University of Pennsylvania | Undergraduate Degree |
| University of Rochester Medical Center | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
- Börse
- Insiders
- Robert Myles Elfont
- Erfahrung
